FIELD: medicine.
SUBSTANCE: invention is related to the use of ranolazine and its analogues for preparation of medicine for treatment of acquired or congenital arrhythmias with elongated QT. The invention ensures efficient treatment with minimum side effects due to the ability of these compounds in therapeutic doses to inhibit IKr, IKs and later INa -ion channels without inhibition of calcium channels.
EFFECT: efficient treatment.
36 cl, 25 dwg, 19 tbl, 50 dwg
